Clinical trial
Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2…
NCT00373178 · Aristotle University Of Thessaloniki, Other · Completed
Key facts
| NCT number | NCT00373178 |
|---|---|
| Title | Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes |
| Official title | Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes |
| Lead sponsor | Aristotle University Of Thessaloniki, Other |
| Collaborators | University of Athens |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | rosiglitazone, metformin, Anti-diabetic medications |
| Enrollment | 100 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Sep 7, 2006 |
| Last update posted | Nov 2, 2012 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: